I agree that this site is using cookies. You can find further informations here.
X
Stass, Heino
44  results:
Search for persons X
?
1

Correction to "Structural and Mechanistic Investigation of ..:

Lang, Dieter ; Schulz, Simone I. ; Piel, Isabel..
Chemical Research in Toxicology.  36 (2023)  5 - p. 790-791 , 2023
Link: https://doi.org/10.1021/..
 
?
2

Nifurtimox for Treatment of Chagas Disease in Pediatric Pat..:

Stass, Heino ; Ince, Ibrahim ; Grossmann, Ulrike..
The AAPS Journal.  24 (2022)  5 - p. , 2022
Link: https://doi.org/10.1208/..
 
?
3

Population Pharmacokinetics of Nifurtimox in Adult and Pedi..:

Ince, Ibrahim ; Prins, Klaas ; Willmann, Stefan...
The Journal of Clinical Pharmacology.  62 (2022)  10 - p. 1273-1284 , 2022
Link: https://doi.org/10.1002/..
 
?
4

Structural and Mechanistic Investigation of the Unusual Met..:

Lang, Dieter ; Schulz, Simone I. ; Piel, Isabel..
Chemical Research in Toxicology.  35 (2022)  11 - p. 2037-2048 , 2022
Link: https://doi.org/10.1021/..
 
?
5

Clinical investigation of the biopharmaceutical characteris..:

Stass, Heino ; Just, Sarah ; Weimann, Boris...
European Journal of Pharmaceutical Sciences.  166 (2021)  - p. 105940 , 2021
Link: https://doi.org/10.1016/..
 
?
6

Safety, tolerability and pharmacokinetics of emodepside, a ..:

Gillon, Jean‐Yves ; Dennison, Jeremy ; van den Berg, Frans...
British Journal of Clinical Pharmacology.  87 (2021)  10 - p. 3949-3960 , 2021
Link: https://doi.org/10.1111/..
 
?
7

Biopharmaceutical Characteristics of Nifurtimox Tablets for..:

Stass, Heino ; Feleder, Ethel ; Garcia‐Bournissen, Facundo...
Clinical Pharmacology in Drug Development.  10 (2020)  5 - p. 542-555 , 2020
Link: https://doi.org/10.1002/..
 
?
8

Pharmacokinetics, Safety, and Tolerability of Single‐Dose I..:

Stass, Heino ; Lettieri, John ; Vanevski, Konstantina M....
The Journal of Clinical Pharmacology.  59 (2019)  5 - p. 654-667 , 2019
Link: https://doi.org/10.1002/..
 
?
9

Application of Physiologically‐Based and Population Pharmac..:

Willmann, Stefan ; Frei, Matthias ; Sutter, Gabriele...
CPT: Pharmacometrics & Systems Pharmacology.  8 (2019)  9 - p. 654-663 , 2019
Link: https://doi.org/10.1002/..
 
?
10

A Physiologically-Based Pharmacokinetic Model to Describe C..:

Schlender, Jan-Frederik ; Teutonico, Donato ; Coboeken, Katrin...
Clinical Pharmacokinetics.  57 (2018)  12 - p. 1613-1634 , 2018
Link: https://doi.org/10.1007/..
 
?
11

Inhalation of a Dry Powder Ciprofloxacin Formulation in Hea..:

Stass, Heino ; Nagelschmitz, Johannes ; Willmann, Stefan...
Clinical Drug Investigation.  33 (2013)  6 - p. 419-427 , 2013
Link: https://doi.org/10.1007/..
 
?
12

Tolerability and Pharmacokinetic Properties of Ciprofloxaci..:

Stass, Heino ; Weimann, Boris ; Nagelschmitz, Johannes..
Clinical Therapeutics.  35 (2013)  10 - p. 1571-1581 , 2013
Link: https://doi.org/10.1016/..
 
?
13

Moxifloxacin does not Alter Ciclosporin Pharmacokinetics in..:

Stass, Heino ; Delesen, Heinz ; Kubitza, Dagmar...
Clinical Drug Investigation.  , 2010
Link: https://doi.org/10.2165/..
 
?
14

Moxifloxacin does not Alter Ciclosporin Pharmacokinetics in..:

Stass, Heino ; Delesen, Heinz ; Kubitza, Dagmar...
Clinical Drug Investigation.  30 (2010)  5 - p. 279-287 , 2010
Link: https://doi.org/10.1007/..
 
?
15

Pharmacokinetics of moxifloxacin in patients with severe se..:

Pletz, Mathias W. ; Bloos, Frank ; Burkhardt, Olaf...
Intensive Care Medicine.  36 (2010)  6 - p. 979-983 , 2010
Link: https://doi.org/10.1007/..
 
1-15